NT_1170x120_1-11-18

Improving Transparency and Accuracy in Medicare Part D Spending Act

NCPA nudges Congress to act on DIR fee bills

NCPA nudges Congress to act on DIR fee bills

ALEXANDRIA, Va. — The National Community Pharmacists Association has called on Congress to hold hearings on legislation that would crack down on direct and indirect remuneration (DIR) fees. NCPA said it has sent letters to the chair and ranking member of the Senate Finance Committee and to the chair and ranking members of the House

Congress reintroduces DIR fee legislation

Congress reintroduces DIR fee legislation

WASHINGTON — Reps. Morgan Griffith (R., Va.) and Peter Welch (D., Vt.) have reintroduced the Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R. 1038), which community pharmacies say would squelch a growing burden: retroactive direct and indirect remuneration (DIR) fees. The bill, introduced Wednesday in the House of Representatives, would ban the application

Senate bill takes aim at DIR fees

Senate bill takes aim at DIR fees

ALEXANDRIA, Va. — Congressional support continues to build for cracking down on direct and indirect remuneration (DIR) fees. The National Community Pharmacists Association said that four U.S. senators on Monday introduced a bill that would boost transparency in Medicare Part D drug spending and prohibit retroactive DIR fees. The Improving Transparency and Accuracy in Medicare

NCPA backs bill cracking down on DIR fees

NCPA backs bill cracking down on DIR fees

ALEXANDRIA, Va. — The National Community Pharmacists Association has endorsed new legislation designed to raise transparency and accuracy in Medicare Part D prescription drug spending and reporting. NCPA said the bill, the Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R. 5951), introduced Thursday, also would ban so-called direct and indirect remuneration (DIR)